Regulatory Aspects of Oncologicals: Nanosystems Main Challenges

Rogério Gaspar(University of Lisbon), Beatriz Silva Lima(University of Lisbon), M. Luísa Corvo(University of Lisbon), M.B.F. Martins(University of Lisbon), Mafalda Videira(University of Lisbon), Liana C. Silva(University of Lisbon), Helena F. Florindo(University of Lisbon)
Advances in delivery science and technology
January 1, 2014
10.1007/978-3-319-08084-0_15
Cited by 30

Related Papers

Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium
|Nature Biotechnology|2010|406
Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases
|Advanced Drug Delivery Reviews|2013|237
Immune system targeting by biodegradable nanoparticles for cancer vaccines
|Journal of Controlled Release|2013|229
Lymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid Nanoparticles
|Journal of drug targeting|2002|210
In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model
|Journal of Controlled Release|2014|140